CHIP contributes to radiotherapy resistance in lung cancer by ubiquitinating and degrading p21, a CDK inhibitor; likewise, CHIP knockdown sensitized lung cancer cells to radiotherapy [137]. Here, STUB1 is linked to lung carcinoma.